SynthesisFrontiers in pharmacology2022

Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studies.

Ruo-Lin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.